Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.

Trial Profile

Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Aug 2016

At a glance

  • Drugs Mosapride/rebamipide (Primary) ; Mosapride
  • Indications Dyspepsia
  • Focus Therapeutic Use
  • Sponsors Ildong Pharmaceutical
  • Most Recent Events

    • 12 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top